Insulet Corporation (Bedford, MA) has announced FDA approval of the new version of its OmniPod insulin delivery system. The system comprises an insulin pump, which has been made 34% smaller and 25% lighter over its predecessor, and a Personal Diabetes Manager (PDM) glucometer that communicates wirelessly with the pump, and now calculates the insulin on board (IOB). The communication between the devices has been improved to allow them to talk over a distance of up to five feet (1.5 meters).
The pump contains the same 200-unit insulin reservoir as the original and can be worn continuously for up to three days. For added safety, the pump now features a pink indicator on its top to indicate that the cannula has been deployed.
From the product page:
The world’s first tubing-free insulin pump, the OmniPod insulin pump System is discreet and durable, wireless and incredibly easy to use.
With just two user-friendly parts that communicate wirelessly, the OmniPod® Insulin Management System simplifies insulin pump therapy. The waterproof Pod integrates the pumping mechanism, cannula, needle, and insulin reservoir into one wearable unit. The PDM (Personal Diabetes Manager) wirelessly programs insulin delivery, calculates suggested doses, and has a convenient, built-in FreeStyle® blood glucose meter.
Press release: FDA Clearance for the New OmniPod System